Divis Laboratories Ltd reported 24.1B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
Aurobindo Pharma INR 78.68B 5.14B Jun/2025
Avita Medical AUD 18.41M 7.89M Dec/2024
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Divis Laboratories Ltd 24.1B 1.75B Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Lupin INR 62.73B 7.16B Jun/2025
Moderna USD 142M 34M Jun/2025
Organon & Co 1.59B 80M Jun/2025
Revvity USD 720M 55M Jun/2025
Tectonic Therapeutic 0 0 Dec/2024
Tilray USD 308.01M 43.78M Jun/2025
Viatris USD 3.57B 320M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025